ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $159,000 | +200.0% | 26,448 | +80.8% | 0.00% | – |
Q3 2019 | $53,000 | -45.4% | 14,630 | -59.6% | 0.00% | -100.0% |
Q2 2019 | $97,000 | +32.9% | 36,201 | -21.7% | 0.00% | 0.0% |
Q4 2018 | $73,000 | +25.9% | 46,216 | +125.6% | 0.00% | 0.0% |
Q2 2018 | $58,000 | +28.9% | 20,490 | +69.3% | 0.00% | – |
Q1 2018 | $45,000 | +40.6% | 12,102 | +9.4% | 0.00% | – |
Q4 2017 | $32,000 | -83.2% | 11,067 | -73.8% | 0.00% | -100.0% |
Q3 2017 | $190,000 | +57.0% | 42,229 | +59.8% | 0.00% | +100.0% |
Q2 2017 | $121,000 | +28.7% | 26,429 | +18.6% | 0.00% | 0.0% |
Q1 2017 | $94,000 | -58.8% | 22,285 | -59.7% | 0.00% | -50.0% |
Q4 2016 | $228,000 | +11.8% | 55,250 | +109.1% | 0.00% | +100.0% |
Q1 2016 | $204,000 | +16.6% | 26,422 | +34.0% | 0.00% | 0.0% |
Q2 2015 | $175,000 | -1.7% | 19,713 | +9.3% | 0.00% | 0.0% |
Q1 2015 | $178,000 | -54.5% | 18,032 | -43.5% | 0.00% | -50.0% |
Q4 2014 | $391,000 | -4.9% | 31,909 | -22.6% | 0.00% | 0.0% |
Q3 2014 | $411,000 | +356.7% | 41,215 | +50.4% | 0.00% | – |
Q1 2014 | $90,000 | +63.6% | 27,400 | +49.7% | 0.00% | – |
Q3 2013 | $55,000 | – | 18,302 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |